AP2012006346A0 - Blood transcriptional signature af active versus latent mycobacterium tuberculosis infection. - Google Patents

Blood transcriptional signature af active versus latent mycobacterium tuberculosis infection.

Info

Publication number
AP2012006346A0
AP2012006346A0 AP2012006346A AP2012006346A AP2012006346A0 AP 2012006346 A0 AP2012006346 A0 AP 2012006346A0 AP 2012006346 A AP2012006346 A AP 2012006346A AP 2012006346 A AP2012006346 A AP 2012006346A AP 2012006346 A0 AP2012006346 A0 AP 2012006346A0
Authority
AP
ARIPO
Prior art keywords
mycobacterium tuberculosis
tuberculosis infection
active versus
transcriptional signature
latent mycobacterium
Prior art date
Application number
AP2012006346A
Other languages
English (en)
Inventor
Anne O'garra
Matthew Berry
Onn Min Kon
Original Assignee
Baylor Res Inst Medical Res Council
Imp College Healthcare Nhs Trust
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor Res Inst Medical Res Council, Imp College Healthcare Nhs Trust filed Critical Baylor Res Inst Medical Res Council
Publication of AP2012006346A0 publication Critical patent/AP2012006346A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AP2012006346A 2009-11-30 2010-08-19 Blood transcriptional signature af active versus latent mycobacterium tuberculosis infection. AP2012006346A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/628,148 US20110129817A1 (en) 2009-11-30 2009-11-30 Blood transcriptional signature of active versus latent mycobacterium tuberculosis infection
PCT/US2010/046042 WO2011066008A2 (en) 2009-11-30 2010-08-19 Blood transcriptional signature of active versus latent mycobacterium tuberculosis infection

Publications (1)

Publication Number Publication Date
AP2012006346A0 true AP2012006346A0 (en) 2012-06-30

Family

ID=44067161

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2012006346A AP2012006346A0 (en) 2009-11-30 2010-08-19 Blood transcriptional signature af active versus latent mycobacterium tuberculosis infection.

Country Status (19)

Country Link
US (2) US20110129817A1 (xx)
EP (1) EP2519652A4 (xx)
JP (1) JP2013511981A (xx)
KR (2) KR20140078768A (xx)
CN (1) CN102844444A (xx)
AP (1) AP2012006346A0 (xx)
AR (1) AR080570A1 (xx)
AU (1) AU2010325179B2 (xx)
BR (1) BR112012013029A2 (xx)
CA (1) CA2782211A1 (xx)
CL (1) CL2012001400A1 (xx)
EA (1) EA201270650A1 (xx)
IL (1) IL220016A0 (xx)
MX (1) MX2012006031A (xx)
PE (1) PE20121690A1 (xx)
SG (1) SG10201407855WA (xx)
TW (1) TW201131032A (xx)
WO (1) WO2011066008A2 (xx)
ZA (1) ZA201204806B (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2524966A1 (en) * 2011-05-18 2012-11-21 Rheinische Friedrich-Wilhelms-Universität Bonn Molecular analysis of tuberculosis
TWI458978B (zh) * 2011-12-27 2014-11-01 Chengchung Chou 判別開放性或潛伏性結核菌感染之方法
WO2013138497A1 (en) * 2012-03-13 2013-09-19 Baylor Research Institute Early detection of tuberculosis treatment response
CA2867481A1 (en) * 2012-04-13 2013-10-17 Somalogic, Inc. Tuberculosis biomarkers and uses thereof
GB201211158D0 (en) * 2012-06-22 2012-08-08 Univ Nottingham Trent Biomarkers and uses thereof
US20150284780A1 (en) * 2012-10-30 2015-10-08 Imperial Innovations Limited Method of detecting active tuberculosis in children in the presence of a co-morbidity
WO2014093872A1 (en) * 2012-12-13 2014-06-19 Baylor Research Institute Blood transcriptional signatures of active pulmonary tuberculosis and sarcoidosis
CA2902068C (en) * 2013-02-28 2023-10-03 Caprion Proteomics Inc. Tuberculosis biomarkers and uses thereof
GB201315748D0 (en) 2013-09-04 2013-10-16 Imp Innovations Ltd Biological methods and materials for use therein
WO2015048098A1 (en) 2013-09-24 2015-04-02 Washington University Diagnostic methods for infectious disease using endogenous gene expression
WO2015159239A1 (en) * 2014-04-15 2015-10-22 Stellenbosch University A method for diagnosing tuberculous meningitis
CN103954755B (zh) * 2014-04-30 2017-04-05 广东省结核病控制中心 一种结核分枝杆菌潜伏感染的诊断试剂盒
US10041945B2 (en) 2014-05-05 2018-08-07 Emory University Methods of diagnosing and treating tuberculosis
CN116218988A (zh) * 2015-10-14 2023-06-06 斯坦福大学托管董事会 用于诊断结核病的方法
GB201519872D0 (en) 2015-11-11 2015-12-23 Univ Cape Town And Ct For Infectious Disease Res Biomarkers for prospective determination of risk for development of active tuberculosis
GB2547034A (en) * 2016-02-05 2017-08-09 Imp Innovations Ltd Biological methods and materials for use therein
KR101888101B1 (ko) * 2016-09-19 2018-08-14 충남대학교산학협력단 Scotin 단백질의 과발현에 의하여 결핵균 생존 및 증식을 억제하는 방법
JP6306124B2 (ja) * 2016-11-01 2018-04-04 国立大学法人高知大学 結核検査用バイオマーカー
CN107653313B (zh) * 2017-09-12 2021-07-09 首都医科大学附属北京胸科医院 Retn和klk1在作为结核病检测标志物中的应用
US11443433B2 (en) * 2018-02-10 2022-09-13 The Trustees Of The University Of Pennsylvania Quantification and staging of body-wide tissue composition and of abnormal states on medical images via automatic anatomy recognition
GB201804019D0 (en) * 2018-03-13 2018-04-25 Univ Cape Town Method for predicting progression to active tuberculosis disease
US11036779B2 (en) * 2018-04-23 2021-06-15 Verso Biosciences, Inc. Data analytics systems and methods
CN108828235A (zh) * 2018-08-23 2018-11-16 中国人民解放军第三〇九医院 Pglyrp1蛋白作为标志物在诊断活动性结核病中的应用
CN109061191B (zh) * 2018-08-23 2021-08-24 中国人民解放军第三〇九医院 S100p蛋白作为标志物在诊断活动性结核病中的应用
CN110286231A (zh) * 2019-06-19 2019-09-27 中国人民解放军总医院第八医学中心 用于检测cd160蛋白的物质在制备用于诊断活动性结核病的产品中的应用
CN111304313A (zh) * 2019-12-13 2020-06-19 南方医科大学 一种检测fpr1基因表达水平的试剂的应用
EP3868894A1 (en) * 2020-02-21 2021-08-25 Forschungszentrum Borstel, Leibniz Lungenzentrum Method for diagnosis and treatment monitoring and individual therapy end decision in tuberculosis infection
CN116994646B (zh) * 2023-08-01 2024-06-11 东莞市滨海湾中心医院(东莞市太平人民医院、东莞市第五人民医院) 一种菌阳活动性肺结核风险评估模型的构建方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6627198B2 (en) * 1997-03-13 2003-09-30 Corixa Corporation Fusion proteins of Mycobacterium tuberculosis antigens and their uses
US6713257B2 (en) * 2000-08-25 2004-03-30 Rosetta Inpharmatics Llc Gene discovery using microarrays
WO2003008647A2 (en) * 2000-11-28 2003-01-30 University Of Cincinnati Blood assessment of injury
EP2196473A1 (en) * 2001-07-04 2010-06-16 Health Protection Agency Mycobacterial antigens expressed during latency
AU2003241055A1 (en) * 2002-06-20 2004-01-06 Glaxo Group Limited Surrogate markers for the determination of the disease status of an individual infected by mycobacterium tuberculosis
NZ590341A (en) * 2008-06-25 2012-07-27 Baylor Res Inst Blood transcriptional signature of mycobacterium tuberculosis infection

Also Published As

Publication number Publication date
AU2010325179B2 (en) 2015-03-12
US20110129817A1 (en) 2011-06-02
WO2011066008A3 (en) 2011-07-21
TW201131032A (en) 2011-09-16
MX2012006031A (es) 2012-10-03
SG10201407855WA (en) 2015-01-29
CA2782211A1 (en) 2011-06-03
EP2519652A2 (en) 2012-11-07
EA201270650A1 (ru) 2013-06-28
BR112012013029A2 (pt) 2016-10-04
EP2519652A4 (en) 2013-05-01
CL2012001400A1 (es) 2014-05-09
WO2011066008A2 (en) 2011-06-03
AU2010325179A1 (en) 2012-07-05
KR20120107979A (ko) 2012-10-04
PE20121690A1 (es) 2012-12-16
AR080570A1 (es) 2012-04-18
IL220016A0 (en) 2012-07-31
ZA201204806B (en) 2013-02-27
KR20140078768A (ko) 2014-06-25
CN102844444A (zh) 2012-12-26
JP2013511981A (ja) 2013-04-11
US20140080732A1 (en) 2014-03-20

Similar Documents

Publication Publication Date Title
AP2012006346A0 (en) Blood transcriptional signature af active versus latent mycobacterium tuberculosis infection.
AP2011005546A0 (en) Blood transcriptional signature of mycobacterium tuberculosis infection.
BRPI1105769A2 (pt) insersores de dispositivo médico e processos de inserção e uso de dispositivos médicos.
PL2443102T3 (pl) Benzoksazynonowe środki chwastobójcze
DK2464143T3 (da) Fremgangsmåde til betjening af et høreapparat, høresystem samt audiogateway-enheder
AP2012006285A0 (en) Insecticidal compounds based on isoxazoline derivatives.
BRPI1009444A2 (pt) Formulações herbicidas compreendendo glifosato e glicerídeos alcoxilados.
EP2508117A4 (en) INSERT AID AND ENDOSCOPE DEVICE
EP2578591A4 (en) NOVEL OXAZOLIDINONE BENZOXAZINE COMPOUNDS, PREPARATION METHODS AND USES THEREOF
WO2009085272A3 (en) Improved medical devices
BR112013018455A2 (pt) dispositivo de ostomia.
IT1403159B1 (it) Dispositivo convertitore.
EP2649449A4 (en) BIOMARKERS FOR TUBERCULOSIS AND HIV / AIDS
BRPI1008952A2 (pt) Composição herbicida.
DK2302953T3 (da) Knogletransmissionshøreapparat.
FR2950407B1 (fr) Dispositif de butee de debrayage.
DE112010004057A5 (de) Kupplungseinrichtung
ITTO20100128U1 (it) Dispositivo limitatore di sovratensione.
IT1394461B1 (it) Dispositivo spollonatore.
ES1073574U8 (es) Saco de dormir.
DK2009955T3 (da) Høreapparat med passiv, indgangsniveauafhængig støjreduktion
CL2007002461S1 (es) Dispositivo medico.
BRPI0920520A2 (pt) benzoxazinas 5-subistituídas
IT1400196B1 (it) Supporto per tapparelle.
TH106787B (th) อุปกรณ์สำหรับการปลูกฝังสำหรับตัวเซ็นเซอร์เมทาบอไลต์